[The experience of using the Russian biosimilar of the original drug eculizumab for the treatment of patients with atypical hemolytic-uremic syndrome].

Autor: Lavrishcheva YV; Almazov National Medical Research Centre., Yakovenko AA; Pavlov First Saint Petersburg State Medical University., Kudlai DA; JSC GENERIUM.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2020 Jul 09; Vol. 92 (6), pp. 76-80. Date of Electronic Publication: 2020 Jul 09.